解读在医院癌症登记处注册的双重初级病例的模式:北印度农村癌症中心的第一次经验
Sankalp Sancheti1, Alok Kumar Goel2, Anshul Singla3
1Department of Pathology, Homi Bhabha Cancer Hospital (Unit of Tata Memorial Centre), Sangrur, Punjab, India.
Journal of laboratory physicians
|October 2, 2023
概括
这项研究分析了印度的双重原发性癌症,发现乳腺,头部/部和妇科部位最常见的初始瘤. 随后的癌症经常发生在胃肠道,妇科部位和头部/部区域.
科学领域:
- 在瘤学瘤学.
- 癌症流行病学 癌症流行病学
- 病理学 病理学 病理学
背景情况:
- 双重原发性恶性瘤存在独特的诊断和治疗挑战.
- 了解这些癌症的模式对于改善患者的治疗结果至关重要.
- 基于医院的癌症登记册 (HBCR) 为流行病学研究提供了有价值的数据.
研究的目的:
- 确定双重原发性恶性瘤的流行病学模式.
- 为了确定常见的初级和二级癌症部位.
- 分析双重癌症的同步性和超时性.
主要方法:
- 数据来源于印度旁遮普邦桑格鲁尔癌症医院的HBCR (2018-2019).
- 使用国际癌症研究机构 (IARC) 规则编码的双重原发性癌症.
- 统计分析包括计算诊断之间的时间间隔.
主要成果:
- 在6,933个注册病例中,发现了45个双重初级病例.
- 64.4%是同步的,35.6%是超时的.
- 最常见的主要部位:乳房 (33%),头部和部 (22.2%),妇科 (11%).
- 最常见的次要部位:胃肠道 (31%),妇科 (18%),头部和部 (16%).
- 乳腺癌显示第二恶性瘤的发病率更高.
结论:
- 乳腺,头,妇科和前列腺癌是常见的初始原发性癌症.
- 胃肠道,妇科和头部部位是二次恶性瘤的常见病例.
- 同步双重瘤占大多数,定期随访对于生存评估至关重要.
相关概念视频
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Prevalence and Incidence
619
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
619
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


